Monitoring of Enterobacteria strains with producing β-lactamases in males with infectious-inflammatory diseases of urogenital tract

Authors

DOI:

https://doi.org/10.26641/2307-0404.2022.2.260282

Keywords:

opportunistic pathogenic microflora, urogenital tract, enterobacteria, β-lactamases, antibiotics, resistance

Abstract

This article presents the findings of investigation of the microflora of 257 males with infectious-inflammatory diseases of the urogenital tract using the test system “Androflor”. The role of representatives of conditionally pathogenic microflora as the main etiological agent in occurrence of infectious-inflammatory diseases of the urogenital tract in males was shown. Its composition in 39.3±3.0% of cases was represented by bacteria of family Enterobacteriaceae, in 10.9±1.9% – by Enterococcus spp., in 3.1±1.1% – by Haemophilus spp. and in 0.4±0.1% of cases – by P. aeruginosa. Out of 101 strains of enterobacteria, 27 representatives had the ability to synthesize β-lactamases 26.7±4.4% of cultures), in particular: 16 isolates of E. coli, 5 isolates of P. mirabilis and 6 isolates of K. pneumoniae. The selected strains of enterobacteria producing β-lactamases appeared to be resistant at least to 6 tested antibiotics, which allowed referring them to categories of multi-resistant. All cultures producing β-lactamases showed resistance to penicillinеs – ampicillin and amoxiclav. In this case, resistance to at least one of the antibiotics of cephalosporin group of the third generation was noted. In addition, 83.3±2.1% of the examined isolates were characterized by resistance to macrolides – erythromycin and azithromycin, as well as to co-trimoxazole and fosfomicin. The obtained data are of practical importance to develop efficient schemes of antibiotic therapy for infectious-inflammatory diseases of the urogenital tract, caused by strains of enterobacteria producing β-lactamases.

References

Antomonov MYu. [Mathematical processing and analysis of medical and biological data]. Kyiv; 2017. p. 579. Russian. Available from: http://www.health.gov.ua/www.nsf/16a436f1b0cca21ec22571b300253d46/522e94120f630ce5c225803b004b3867/$FILE/Antomonov_monogr_titul%2BOGLAVL%2Bvvedenie.pdf

Aminul P, Anwar S, Molla M, Miah R. Evaluation of antibiotic resistance patterns in clinical isolates of Klebsiella pneumoniae in Bangladesh. Biosafety and Health. 2021;3(6):301-6. doi: https://doi.org/10.1016/j.bsheal.2021.11.001

Ayelign B, Abebe B, Shibeshi A, Meshesha S, Shibabaw T, Addis Z, et al. Bacterial isolates and their antimicrobial susceptibility patterns among pediatric patients with urinary tract infections. Turk J Urol. 2018;44(1):62-69. doi: https://doi.org/10.5152/tud.2017.33678

Ben Ashur A, El Magrahi H, Elkammoshi A, Al-sharif H. Prevalence and antibiotics susceptibility pattern of urine bacterial isolates from Tripoli Medical Center (TMC), Tripoli, Libya. Iberoam J Med. 2021;3(3):221-6. doi: https://doi.org/10.53986/ibjm.2021.0035

Caron Y, Chheang R, Puthea N, Soda M, Boyer S, Tarantola A, Kerleguer A. Beta-lactam resistance among Enterobacteriaceae in Cambodia: The four-year itch. Int J Infect Dis. 2018;66:74-79. doi: https://doi.org/10.1016/j.ijid.2017.10.025

Bush K, Bradford PA. Epidemiology of β-lacta-mase-producing pathogens. Clin Microbiol Rev. 2020;33(2):e00047-19. doi: https://doi.org/10.1128/CMR.00047-19

Madrazo M, Esparcia A, Lopez-Cruz I, Albe-rola J, Piles L, Viana A, et al. Clinical impact of multidrug-resistant bacteria in older hospitalized patients with community-acquired urinary tract infection. BMC Infect Dis. 2021;21(1):1232. doi: https://doi.org/10.1186/s12879-021-06939-2

CLSI. Methods for dilution antimicrobial suscep-tibility tests for bacteria that grow aerobically. 11th ed. CLSI standart M07. Wayne, PA: Clinical and Laboratory Standarts Institute; 2018;13. Аvailable from: https://clsi.org/media/1928/m07ed11_sample.pdf

CLSI. Performance Standards for Antimicrobial Susceptibility Testing. 30th ed. CLSI supplement M100. Wayne, PA: Clinical and Laboratory Standards Institute; 2020;332. Аvailable from: https://www.nih.org.pk/wp-content/uploads/2021/02/CLSI-2020.pdf

Rajivgandhi G, Maruthupandy M, Ramachan-dran G, Priyanga M, Manoharan N. Detection of ESBL genes from ciprofloxacin resistant Gram negative bacteria isolated from urinary tract infections (UTIs). Front Lab Med. 2018;2(1):5-13. doi: https://doi.org/10.1016/j.flm.2018.01.001

Anesi JA, Lautenbach E, Nachamkin I, Gar-rigan C, Bilker WB, Omorogbe J, et al. Poor clinical out-comes associated with community-onset urinary tract infections due to extended-spectrum cephalosporin-resis-tant Enterobacteriaceae. Infect Control Hosp Epidemiol. 2018;39(12):1431-5. doi: https://doi.org/10.1017/ice.2018.254

Siles-Guerrero V, Cardona-Benavedes I, Liebana-Martos C, Vasquez-Alonso F, Exposito-Ruiz M, Navarro-Mari JM, Gutierrez-Fernandez J. Recent clininical rele-vance of mono-genital colonization/infection by Urea-plasma parvum. Eur J Clin Microbiol Infect Dis. 2020;39:1899-905. doi: https://doi.org/10.1007/s10096-020-03928-2

Downloads

Published

2022-06-28

How to Cite

1.
Sklyar T, Lavrentievа K, Kurahina N, Lykholat T, Papiashvili M, Lykholat O, Stepanskyi D. Monitoring of Enterobacteria strains with producing β-lactamases in males with infectious-inflammatory diseases of urogenital tract. Med. perspekt. [Internet]. 2022Jun.28 [cited 2024Dec.27];27(2):110-8. Available from: https://journals.uran.ua/index.php/2307-0404/article/view/260282

Issue

Section

CLINICAL MEDICINE